Study analysis · The Cochrane database of systematic reviews · 2013
Vitamin C won't stop your cold—unless you're a marathon runner.
Taking vitamin C every day doesn't prevent colds for most people, but it cuts the risk in half for athletes and shortens colds slightly for everyone.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study is like a super-summary of many experiments where people took vitamin C or a fake pill. It found that taking vitamin C every day doesn't stop you from catching a cold, but it might make your cold get better a little faster. However, taking vitamin C after you already have a cold doesn't seem to help.
What’s the bottom line?
This review looked at many studies to see if taking vitamin C every day or at the start of a cold makes a difference.
How strong is this study?
This study is very well done because it combined results from many good experiments where neither the researchers nor the participants knew who got the real vitamin C. This reduces cheating and mistakes. Because it's a summary of many studies, we can trust the results more than if it were just one small study.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 539 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design can establish causation. Causation can be established for outcomes where consistent effects were found across multiple double-blind RCTs, such as reduction in cold duration and severity with regular supplementation. However, for prevention in the general population, no effect was found, so no causal claim. For therapeutic use, evidence is insufficient to establish causation.
No Conflicts
No conflicts of interest identified
No conflicts of interest identified in the provided abstract; review appears independently conducted.
Independent Analysis Safeguards
- Two review authors independently extracted data.
- Majority of included trials were randomized and double-blind; exclusion of non-randomized or non-double-blind trials did not affect conclusions.
Full review may contain conflict of interest and funding statements not included in the abstract.
Key takeaways
- 01
For most people, vitamin C doesn't stop you from catching a cold.
- 02
But for people who do hard exercise (like marathon runners), it cuts the risk in half.
- 03
It also makes colds a little shorter—about 8% shorter for adults and 14% for children.
- 04
Taking it after you already have a cold doesn't seem to help.
- 05
The effect is small for most people, but for athletes it's big.
- 06
The benefit on duration is modest—a cold that lasts 7 days might be cut by half a day to a day.
Surprising findings
- Vitamin C halves cold risk in physically stressed individuals but does nothing for the general population.Common belief is that vitamin C boosts immunity for everyone, but the data show it only helps under extreme physical stress like marathon running or military training.
- Therapeutic vitamin C (starting after symptoms) shows no consistent effect, contradicting widespread use.Many people believe that high-dose vitamin C at the first sign of a cold can 'stop it in its tracks', but meta-analysis finds no evidence for this.
Practical takeaways
If you are a runner, skier, or soldier in extreme conditions, consider taking at least 200 mg vitamin C daily to cut cold risk by half.
This does not apply to most people—the effect was only seen in those undergoing brief periods of severe physical stress.
high confidenceFor the average person, daily vitamin C can shorten a cold by about half a day to a day.
The effect is small and requires consistent daily intake—not just when you feel sick.
medium confidenceDon't rely on vitamin C supplements once you already have cold symptoms—the evidence says it won't help.
A few studies with very high doses (8 g at onset) showed some benefit, but overall meta-analysis found no consistent effect.
high confidenceWhy this study matters
The marathon runner exception
In five trials of marathon runners, skiers, and soldiers in subarctic conditions, regular vitamin C supplementation (≥200 mg/day) reduced cold risk by 52% (RR 0.48, 95% CI 0.35–0.64). For the general population, there was no effect (RR 0.97, CI 0.94–1.00).
This huge difference shows that stress and exercise change how vitamin C works—a fact most people don't know.
Shorter colds, not prevented colds
Regular vitamin C shortens colds by 8% in adults and 14% in children. For a 7-day cold, that's about half a day to a day less. In children, higher doses (1–2 g/day) shortened colds by 18%.
The effect is modest but consistent—worth knowing if you get frequent colds.
Therapeutic vitamin C doesn't work
Seven trials testing vitamin C started after symptoms began showed no consistent benefit on cold duration or severity. Despite this, the review authors suggest individual patients might still test it due to low cost and safety.
Most people take vitamin C when they feel a cold coming on—but the science says that's useless.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This review looked at many studies to see if taking vitamin C every day or at the start of a cold makes a difference.
Research results
For most people, vitamin C doesn't stop you from catching a cold. But for people who do hard exercise (like marathon runners), it cuts the risk in half. It also makes colds a little shorter—about 8% shorter for adults and 14% for children. Taking it after you already have a cold doesn't seem to help.
What this means - more context
The effect is small for most people, but for athletes it's big. The benefit on duration is modest—a cold that lasts 7 days might be cut by half a day to a day.
To determine whether vitamin C reduces the incidence, duration, or severity of the common cold when used as regular daily supplementation or as therapy at symptom onset.
Regular vitamin C (≥200 mg/day) does not reduce cold incidence in the general population (RR 0.97, 95% CI 0.94–1.00) but reduces risk by ~52% in physically stressed individuals (marathon runners, skiers, soldiers). It modestly reduces cold duration (8% in adults, 14% in children) and severity. Therapeutic vitamin C at onset shows no consistent effect.
Methods Used
Meta-analysis of placebo-controlled RCTs; 29 trials (11,306 participants) for incidence, 31 comparisons (9,745 episodes) for duration, 7 comparisons (3,249 episodes) for therapeutic use.
Main Finding
No preventive effect in general population; significant prevention in physically stressed groups; modest reduction in duration and severity with regular supplementation; no clear benefit from therapeutic use.
Confidence Level
High (large number of mostly randomized, double-blind trials with consistent results).
Study Flags
Red Flags
- •No effect on cold incidence in general population
- •Therapeutic use shows no consistent benefit
- •Few therapeutic trials in children
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Vitamin C halves cold risk in physically stressed individuals but does nothing for the general population.
Common belief is that vitamin C boosts immunity for everyone, but the data show it only helps under extreme physical stress like marathon running or military training.
Practical Takeaways
If you are a runner, skier, or soldier in extreme conditions, consider taking at least 200 mg vitamin C daily to cut cold risk by half.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 539 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Human Meta-Analysis
Subject
Lower probability
on the GRADE evidence scale
This study is like a super-summary of many experiments where people took vitamin C or a fake pill. It found that taking vitamin C every day doesn't stop you from catching a cold, but it might make your cold get better a little faster. However, taking vitamin C after you already have a cold doesn't seem to help.
The study has a COI section but no disclosure was found. A small penalty has been applied.
Strengths
- Systematic review with comprehensive search strategy
- Includes only double-blind, placebo-controlled RCTs
- Large sample size (over 11,000 participants for incidence)
Weaknesses
- Heterogeneity in populations and dosages across trials
- Few therapeutic trials available, limiting conclusions for that use
- Some outcomes (e.g., severity) may rely on subjective reporting
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This review looked at many studies to see if taking vitamin C every day or at the start of a cold makes a difference.
Research results
For most people, vitamin C doesn't stop you from catching a cold. But for people who do hard exercise (like marathon runners), it cuts the risk in half. It also makes colds a little shorter—about 8% shorter for adults and 14% for children. Taking it after you already have a cold doesn't seem to help.
What this means - more context
The effect is small for most people, but for athletes it's big. The benefit on duration is modest—a cold that lasts 7 days might be cut by half a day to a day.
To determine whether vitamin C reduces the incidence, duration, or severity of the common cold when used as regular daily supplementation or as therapy at symptom onset.
Regular vitamin C (≥200 mg/day) does not reduce cold incidence in the general population (RR 0.97, 95% CI 0.94–1.00) but reduces risk by ~52% in physically stressed individuals (marathon runners, skiers, soldiers). It modestly reduces cold duration (8% in adults, 14% in children) and severity. Therapeutic vitamin C at onset shows no consistent effect.
Methods Used
Meta-analysis of placebo-controlled RCTs; 29 trials (11,306 participants) for incidence, 31 comparisons (9,745 episodes) for duration, 7 comparisons (3,249 episodes) for therapeutic use.
Main Finding
No preventive effect in general population; significant prevention in physically stressed groups; modest reduction in duration and severity with regular supplementation; no clear benefit from therapeutic use.
Confidence Level
High (large number of mostly randomized, double-blind trials with consistent results).
Study Flags
Red Flags
- •No effect on cold incidence in general population
- •Therapeutic use shows no consistent benefit
- •Few therapeutic trials in children
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Vitamin C halves cold risk in physically stressed individuals but does nothing for the general population.
Common belief is that vitamin C boosts immunity for everyone, but the data show it only helps under extreme physical stress like marathon running or military training.
Practical Takeaways
If you are a runner, skier, or soldier in extreme conditions, consider taking at least 200 mg vitamin C daily to cut cold risk by half.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 539 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Human Meta-Analysis
Subject
Lower probability
on the GRADE evidence scale
This study is like a super-summary of many experiments where people took vitamin C or a fake pill. It found that taking vitamin C every day doesn't stop you from catching a cold, but it might make your cold get better a little faster. However, taking vitamin C after you already have a cold doesn't seem to help.
The study has a COI section but no disclosure was found. A small penalty has been applied.
Strengths
- Systematic review with comprehensive search strategy
- Includes only double-blind, placebo-controlled RCTs
- Large sample size (over 11,000 participants for incidence)
Weaknesses
- Heterogeneity in populations and dosages across trials
- Few therapeutic trials available, limiting conclusions for that use
- Some outcomes (e.g., severity) may rely on subjective reporting
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study is very well done because it combined results from many good experiments where neither the researchers nor the participants knew who got the real vitamin C. This reduces cheating and mistakes. Because it's a summary of many studies, we can trust the results more than if it were just one small study.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 539 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design can establish causation. Causation can be established for outcomes where consistent effects were found across multiple double-blind RCTs, such as reduction in cold duration and severity with regular supplementation. However, for prevention in the general population, no effect was found, so no causal claim. For therapeutic use, evidence is insufficient to establish causation.
No Conflicts
No conflicts of interest identified
No conflicts of interest identified in the provided abstract; review appears independently conducted.
Independent Analysis Safeguards
- Two review authors independently extracted data.
- Majority of included trials were randomized and double-blind; exclusion of non-randomized or non-double-blind trials did not affect conclusions.
Full review may contain conflict of interest and funding statements not included in the abstract.